ArticleJournal of medical physics
Enhancing Prostate Cancer Detection: Integrating Multiparametric Magnetic Resonance Imaging and
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Early and accurate detection of clinically significant prostate cancer (PCa) is crucial for effective patient management. Traditional diagnostic methods, including systematic biopsy guided by transrectal ultrasound, have limitations in detecting significant cancers. Multiparametric magnetic resonance imaging (mpMRI) has shown promise in overcoming these limitations, but it remains operator-dependent and may miss some significant cases. This study explores the integration of mpMRI with Materials and Methods: This study included 15 patients with suspected PCa, who underwent mpMRI and Results: MpMRI demonstrated an AUC of 0.91, with a sensitivity of 77% and specificity of 89% at the selected threshold (Prostate Imaging-Reporting and Data System 4). PET/CT alone showed an AUC of 0.89, with higher sensitivity (90%) but lower specificity (72%). The combination of mpMRI and PET/CT did not significantly improve the overall diagnostic performance, as indicated by a net reclassification index of -3% ( Conclusions: While
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.